Drug discovery todayHumansAnimalsEye DiseasesAngiogenesis InhibitorsVascular Endothelial Growth Factor A
Therapeutic strategies targeting ocular vasculopathies: Current advances and emerging challenges.
Julie Le Du, Cyril Ronco
Published: 202510.1016/j.drudis.2025.104496
Abstract
Ocular vasculopathies, including neovascular age-related macular degeneration (wet AMD), diabetic retinopathy, retinal vein occlusion, and radiation maculopathy, are major causes of vision loss driven by vascular endothelial growth factor (VEGF)-medi…
Preview only. Read the full abstract at the source